Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Anti-MuSK antibody positive my...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Anti-MuSK antibody positive myasthenia gravis with Graves disease: one case report

Anti-MuSK antibody positive myasthenia gravis with Graves disease: one case report

DOI: 10.3969/j.issn.1672-6731.2019.02.012

Bibliographic Details
Main Authors: Shan CAO, Hong-jun HAO, Yong-gang LIU, Cui-jian REN, Yun-he XU, Xiao-mei ZHAO, Jing ZHAO
Format: Article
Language:English
Published: Tianjin Huanhu Hospital 2019-02-01
Series:Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:
Myasthenia gravis
Graves disease
Receptor protein-tyrosine kinases
Receptors, cholinergic
Case reports
Online Access:http://www.cjcnn.org/index.php/cjcnn/article/view/1915
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.cjcnn.org/index.php/cjcnn/article/view/1915

Similar Items

  • Progress in rituximab for anti⁃MuSK antibody-related myasthenia gravis
    by: Ting LI, et al.
    Published: (2020-01-01)
  • Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China
    by: Zunwei Zhang, et al.
    Published: (2020-10-01)
  • Juvenile Generalized Myasthenia Gravis With AChR and MuSK Antibody Double Positivity: A Case Report With a Review of the Literature
    by: XiuShan Ge, et al.
    Published: (2022-05-01)
  • Efficacy and safety of rituximab in the treatment of refractory myasthenia gravis: Meta-analysis
    by: Shan-shan CHU, et al.
    Published: (2018-07-01)
  • Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
    by: Cao, M
    Published: (2021)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs